tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Neurizon Therapeutics Reports Promising Study Results on NUZ-001
Company AnnouncementsNeurizon Therapeutics Reports Promising Study Results on NUZ-001
5d ago
Neurizon’s NUZ-001 Shows Promise in Neurodegenerative Disease Treatment
PremiumCompany Announcements
Neurizon’s NUZ-001 Shows Promise in Neurodegenerative Disease Treatment
8d ago
Neurizon Therapeutics Advances ALS Treatment with Promising Trial Updates
PremiumCompany Announcements
Neurizon Therapeutics Advances ALS Treatment with Promising Trial Updates
15d ago
Neurizon Therapeutics Takes Proactive Steps to Lift FDA Hold on ALS Drug
PremiumCompany Announcements
Neurizon Therapeutics Takes Proactive Steps to Lift FDA Hold on ALS Drug
23d ago
Neurizon Therapeutics Reports Significant Loss Amidst Strategic Shift
PremiumCompany Announcements
Neurizon Therapeutics Reports Significant Loss Amidst Strategic Shift
2M ago
Neurizon Therapeutics to Present Half-Year Results and FDA Feedback on ALS Treatment
PremiumCompany AnnouncementsNeurizon Therapeutics to Present Half-Year Results and FDA Feedback on ALS Treatment
2M ago
Neurizon Receives FDA Guidance on NUZ-001 IND Application
Premium
Company Announcements
Neurizon Receives FDA Guidance on NUZ-001 IND Application
2M ago
Neurizon Therapeutics Announces Half-Year Update Webinar
Premium
Company Announcements
Neurizon Therapeutics Announces Half-Year Update Webinar
2M ago
Director’s Interest Update at Neurizon Therapeutics
PremiumCompany Announcements
Director’s Interest Update at Neurizon Therapeutics
2M ago
Neurizon Secures US Patent for NUZ-001, Strengthening Market Position
PremiumCompany Announcements
Neurizon Secures US Patent for NUZ-001, Strengthening Market Position
2M ago
Neurizon Therapeutics Issues Unlisted Options in Employee Incentive Scheme
PremiumCompany Announcements
Neurizon Therapeutics Issues Unlisted Options in Employee Incentive Scheme
2M ago
Neurizon Therapeutics Advances ALS Treatment with Promising Results and Regulatory Milestones
PremiumCompany Announcements
Neurizon Therapeutics Advances ALS Treatment with Promising Results and Regulatory Milestones
2M ago
Neurizon Therapeutics Faces FDA Hold on NUZ-001 IND Application
PremiumCompany AnnouncementsNeurizon Therapeutics Faces FDA Hold on NUZ-001 IND Application
3M ago
Neurizon Therapeutics Enhances Shareholder Services with Registry Switch
Premium
Company Announcements
Neurizon Therapeutics Enhances Shareholder Services with Registry Switch
3M ago
Neurizon Therapeutics Expands Shareholding Amid ALS Treatment Push
Premium
Company Announcements
Neurizon Therapeutics Expands Shareholding Amid ALS Treatment Push
3M ago
Neurizon Therapeutics Lists New Shares on ASX
PremiumCompany Announcements
Neurizon Therapeutics Lists New Shares on ASX
3M ago
Neurizon Therapeutics Moves Forward with ALS Trial
PremiumCompany Announcements
Neurizon Therapeutics Moves Forward with ALS Trial
4M ago
Neurizon Secures EU Orphan Status for ALS Drug
PremiumCompany Announcements
Neurizon Secures EU Orphan Status for ALS Drug
4M ago
Neurizon Therapeutics Sets Positive 2025 Outlook
PremiumCompany Announcements
Neurizon Therapeutics Sets Positive 2025 Outlook
4M ago
Neurizon Therapeutics Hosts Insightful Webinar on Future Plans
PremiumCompany AnnouncementsNeurizon Therapeutics Hosts Insightful Webinar on Future Plans
4M ago
Neurizon Therapeutics Expands Share Issuance Amid ALS Focus
Premium
Company Announcements
Neurizon Therapeutics Expands Share Issuance Amid ALS Focus
4M ago
Neurizon Therapeutics Boosts ASX Presence with New Securities
Premium
Company Announcements
Neurizon Therapeutics Boosts ASX Presence with New Securities
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >